[Pharmacogenetics for patient care in France: A discipline that evolves!]
La pharmacogénétique au service du soin en France : une discipline qui évolue !
Drug label
Dépistage pré-thérapeutique
Ethics
Next generation sequençing
Pharmacogenetics
Pharmacogénétique
Pretherapeutic screening
Réseau national de pharmacogénétique
Résumé des caractéristiques du produit
Séquençage à haut débit
Éthique
Journal
Therapie
ISSN: 1958-5578
Titre abrégé: Therapie
Pays: France
ID NLM: 0420544
Informations de publication
Date de publication:
Historique:
received:
15
05
2019
revised:
12
08
2019
accepted:
24
09
2019
pubmed:
27
11
2019
medline:
18
9
2021
entrez:
27
11
2019
Statut:
ppublish
Résumé
Pharmacogenetics, which concepts are known for a long time, is entering a new period at least as far as its practical applications for patients are concerned. In recent years there have been more and more initiatives to promote widespread dissemination, and health authorities are increasingly incorporating these concepts into drug labels. In France, the national network of pharmacogenetics (RNPGx) works to promote these activities, both with health actors (biologists, clinicians) and health authorities. This article reviews the current situation in France and the milestones of the year 2018. It highlights recent advances in this field, in terms of currently recommended analyses, sharing of information or technological developments, and the prospects for future developments in the near future from targeted pharmacogenetics to eventually preemptive approaches.
Identifiants
pubmed: 31767126
pii: S0040-5957(19)30154-4
doi: 10.1016/j.therap.2019.09.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
459-470Informations de copyright
Copyright © 2019 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.